(Q28363444)

2

0 references

C Corriveau

3

0 references

N Robillard

4

0 references

S Trottier

5

0 references

S Van Slycken

6

0 references

R A Crann

7

0 references

L A Locke

8

0 references

R Saltzman

9

0 references

A G Palestine

British Journal of Ophthalmology

10

0 references

language of work or name

English

0 references

publication date

May 2001

0 references

published in

0 references

volume

85

0 references

issue

5

0 references

page(s)

576-81

0 references

cites work

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Management of ophthalmic zoster

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Complications of herpes zoster ophthalmicus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Pharmacokinetics of acyclovir after intravenous and oral administration.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Oral acyclovir in acute herpes zoster

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Oral acyclovir for herpes zoster ophthalmicus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723970

Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11316720

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral acyclovir in the treatment of herpes zoster in general practice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11316720

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral acyclovir in herpes zoster ophthalmicus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11316720